FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

783573003: Product containing ravulizumab (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3759386017 Product containing ravulizumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3759387014 Ravulizumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3759386017 Product containing ravulizumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3759387014 Ravulizumab-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5591701000241113 produit contenant du ravulizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5591701000241113 produit contenant du ravulizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing ravulizumab (medicinal product) Is a Immunomodulator-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ravulizumab (medicinal product) Is a Product containing monoclonal antibody (product) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ravulizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ravulizumab (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only ravulizumab (medicinal product) Is a True Product containing ravulizumab (medicinal product) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ravulizumab in parenteral dose form (medicinal product form) Is a True Product containing ravulizumab (medicinal product) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start